INO - Inovio Pharmaceuticals Inc
IEX Last Trade
7.21
-0.110 -1.526%
Share volume: 207,284
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.32
-0.11
-1.50%
Summary score
24%
Profitability
25%
Dept financing
8%
Liquidity
69%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.93%
Return on assets
-14.29%
Return on sales
-19216.63%
Return on invested capital
455.17%
Total debt ratio
26.34%
Debt ratio change over timeo
-0.86%
Current Ratio
6.8%
Quick Ratio
6.8%
Cash Position Ratio
6.03%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-24.78%
Return on assets
-17.33%
Return on sales
-16257.15%
Return on invested capital
226.35%
Total debt ratio
28.5%
Debt ratio change over timeo
-0.82%
Current Ratio
4.07%
Quick Ratio
4.07%
Cash Position Ratio
3.88%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-32.26%
Return on assets
-24.48%
Return on sales
0%
Return on invested capital
510.4%
Total debt ratio
26.85%
Debt ratio change over time
-0.73%
Current Ratio
4.77%
Quick Ratio
4.77%
Cash Position Ratio
4.51%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-114.73%
Return on assets
-106.78%
Return on sales
-7048.14%
Return on invested capital
-37.04%
Total debt ratio
-85.96%
Debt ratio change over time
-0.86%
Current Ratio
-0.1%
Quick Ratio
-0.1%
Cash Position Ratio
-0.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -21.93% | 13.79% | 34.47% | 7.43% |
| Return on assets | -14.29% | 2.76% | 3.15% | 5.62% |
| Return on sales | -19216.63% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 455.17% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 56% |
| Total debt ratio | 26.34% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.86% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 4.07% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.88% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 17% | 39% |
| Short-term ratios | INO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.78% | 13.77% | 13.25% | 3.8% |
| Return on assets | -17.33% | 2.43% | 1.89% | 3.09% |
| Return on sales | -16257.15% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 226.35% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 28.5% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.82% | 46.38% | -72.08% | 1.51% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 4.07% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.88% | 0.36% | 1.28% | 2.93% |
| Liquididy | 66% | 11% | 28% | 69% |